Search research articles
Contact Us
Filters
Showing results (161-170 of 302) with videos related to
Page
of 31
Sort By:
Antiviral Therapy
|
August 24, 2007
Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients
Lauro J Waters, Graeme Moyle, Stefano Bonora, et al.
The Journal of Antimicrobial Chemotherapy
|
March 16, 2013
Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients
Andrea Calcagno, Silvia Nozza, Daniel Gonzalez de Requena, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2020
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders
Andrea Calcagno, Ivano Dal Conte, Dario Cattaneo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis
Marco Merli, Laura Galli, Letizia Marinaro, et al.
Journal of Clinical Pharmacology
|
June 7, 2018
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations
Sarah Allegra, Chiara Simona Cardellino, Giovanna Fatiguso, et al.
Progress in Cardiovascular Diseases
|
March 6, 2016
HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era
Flavia Ballocca, Sebastiano Gili, Fabrizio D'Ascenzo, et al.
Journal of the International AIDS Society
|
November 15, 2014
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
Alessandro Cozzi-Lepri, Andrea Antinori, Stefano Bonora, et al.
AIDS (London, England)
|
September 22, 2006
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide
Daniel González de Requena, Andrea Calcagno, Stefano Bonora, et al.
The Journal of Infection
|
March 22, 2006
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient
Francesco G De Rosa, Sabrina Audagnotto, Olivia Bargiacchi, et al.
Journal of Medical Virology
|
October 15, 2013
Local and global spatio-temporal dynamics of HIV-1 subtype F1
Alessia Lai, Massimo Ciccozzi, Marco Franzetti, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 302) with videos related to
Sort By:
Page
of 31
Antiviral Therapy
|
August 24, 2007
Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients
Lauro J Waters, Graeme Moyle, Stefano Bonora, et al.
The Journal of Antimicrobial Chemotherapy
|
March 16, 2013
Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients
Andrea Calcagno, Silvia Nozza, Daniel Gonzalez de Requena, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2020
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders
Andrea Calcagno, Ivano Dal Conte, Dario Cattaneo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis
Marco Merli, Laura Galli, Letizia Marinaro, et al.
Journal of Clinical Pharmacology
|
June 7, 2018
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations
Sarah Allegra, Chiara Simona Cardellino, Giovanna Fatiguso, et al.
Progress in Cardiovascular Diseases
|
March 6, 2016
HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era
Flavia Ballocca, Sebastiano Gili, Fabrizio D'Ascenzo, et al.
Journal of the International AIDS Society
|
November 15, 2014
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
Alessandro Cozzi-Lepri, Andrea Antinori, Stefano Bonora, et al.
AIDS (London, England)
|
September 22, 2006
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide
Daniel González de Requena, Andrea Calcagno, Stefano Bonora, et al.
The Journal of Infection
|
March 22, 2006
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient
Francesco G De Rosa, Sabrina Audagnotto, Olivia Bargiacchi, et al.
Journal of Medical Virology
|
October 15, 2013
Local and global spatio-temporal dynamics of HIV-1 subtype F1
Alessia Lai, Massimo Ciccozzi, Marco Franzetti, et al.
Page
of 31